Sabine Paternot

938 total citations
19 papers, 733 citations indexed

About

Sabine Paternot is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Sabine Paternot has authored 19 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Cell Biology. Recurrent topics in Sabine Paternot's work include Cancer-related Molecular Pathways (18 papers), Microtubule and mitosis dynamics (8 papers) and Ubiquitin and proteasome pathways (7 papers). Sabine Paternot is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Microtubule and mitosis dynamics (8 papers) and Ubiquitin and proteasome pathways (7 papers). Sabine Paternot collaborates with scholars based in Belgium, United States and Ireland. Sabine Paternot's co-authors include Pierre P. Roger, Katia Coulonval, Laurence Bockstaele, Xavier Bisteau, Jacques E. Dumont, Jacques E. Dumont, Lifu Wang, Thurl E. Harris, Tatjana Arsenijevic and Jaime Miguel Gomes Pita and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Sabine Paternot

19 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabine Paternot Belgium 16 409 387 249 165 90 19 733
Katia Coulonval Belgium 20 456 1.1× 609 1.6× 220 0.9× 175 1.1× 136 1.5× 28 1.1k
Kenneth E. Hook United States 9 338 0.8× 415 1.1× 109 0.4× 73 0.4× 61 0.7× 15 785
Heidelinde Jäkel Austria 12 281 0.7× 453 1.2× 47 0.2× 113 0.7× 70 0.8× 16 687
Eneda Toska United States 17 263 0.6× 855 2.2× 227 0.9× 77 0.5× 210 2.3× 36 1.1k
Thai H. Tran United States 18 426 1.0× 494 1.3× 83 0.3× 71 0.4× 155 1.7× 31 853
Moshit Lindzen Israel 20 393 1.0× 524 1.4× 196 0.8× 43 0.3× 73 0.8× 32 889
Meaghan A. Delaney United States 6 255 0.6× 449 1.2× 145 0.6× 61 0.4× 140 1.6× 7 714
Meejeon Roh United States 14 254 0.6× 407 1.1× 133 0.5× 90 0.5× 115 1.3× 21 740
Thomas Frogne Denmark 9 217 0.5× 313 0.8× 65 0.3× 92 0.6× 59 0.7× 11 557
Elizabeth Luis United States 15 275 0.7× 497 1.3× 93 0.4× 57 0.3× 57 0.6× 18 885

Countries citing papers authored by Sabine Paternot

Since Specialization
Citations

This map shows the geographic impact of Sabine Paternot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Paternot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Paternot more than expected).

Fields of papers citing papers by Sabine Paternot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Paternot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Paternot. The network helps show where Sabine Paternot may publish in the future.

Co-authorship network of co-authors of Sabine Paternot

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Paternot. A scholar is included among the top collaborators of Sabine Paternot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Paternot. Sabine Paternot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Paternot, Sabine, Eric Raspé, Maxime Tarabichi, et al.. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4 /6 inhibition. Molecular Oncology. 18(4). 866–894. 6 indexed citations
2.
Coulonval, Katia, Vincent Vercruysse, Sabine Paternot, et al.. (2021). Monoclonal antibodies to activated CDK4: use to investigate normal and cancerous cell cycle regulation and involvement of phosphorylations of p21 and p27. Cell Cycle. 21(1). 12–32. 6 indexed citations
3.
Paternot, Sabine, Jaime Miguel Gomes Pita, Xavier Bisteau, et al.. (2017). JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. Oncogene. 36(30). 4349–4361. 19 indexed citations
4.
Coulonval, Katia, Jaime Miguel Gomes Pita, Sabine Paternot, et al.. (2017). Abstract P6-07-02: CDK4 phosphorylation status and corresponding gene expression profile predict sensitivity to Palbociclib. Cancer Research. 77(4_Supplement). P6–7. 1 indexed citations
5.
Raspé, Eric, Katia Coulonval, Jaime Miguel Gomes Pita, et al.. (2017). CDK 4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib. EMBO Molecular Medicine. 9(8). 1052–1066. 62 indexed citations
6.
Paternot, Sabine, et al.. (2014). The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes. Cell Cycle. 13(18). 2879–2888. 33 indexed citations
7.
Bisteau, Xavier, Sabine Paternot, Katia Coulonval, et al.. (2013). CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point. PLoS Genetics. 9(5). e1003546–e1003546. 53 indexed citations
9.
Wang, Lifu, Sabine Paternot, Katia Coulonval, et al.. (2010). cAMP-Dependent Activation of Mammalian Target of Rapamycin (mTOR) in Thyroid Cells. Implication in Mitogenesis and Activation of CDK4. Molecular Endocrinology. 24(7). 1453–1468. 55 indexed citations
11.
Bockstaele, Laurence, Xavier Bisteau, Sabine Paternot, & Pierre P. Roger. (2009). Differential Regulation of Cyclin-Dependent Kinase 4 (CDK4) and CDK6, Evidence that CDK4 Might Not Be Activated by CDK7, and Design of a CDK6 Activating Mutation. Molecular and Cellular Biology. 29(15). 4188–4200. 63 indexed citations
12.
Rocha, Ana Sofia, Sabine Paternot, Katia Coulonval, et al.. (2008). Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation. Molecular Biology of the Cell. 19(11). 4814–4825. 42 indexed citations
13.
Bockstaele, Laurence, et al.. (2006). Regulation of CDK4. Cell Division. 1(1). 25–25. 58 indexed citations
14.
Paternot, Sabine, Jacques E. Dumont, & Pierre P. Roger. (2006). Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture. Molecular Endocrinology. 20(12). 3279–3292. 25 indexed citations
15.
Bockstaele, Laurence, Frédérick Libert, Sabine Paternot, et al.. (2006). Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK “Inhibitors”. Molecular and Cellular Biology. 26(13). 5070–5085. 52 indexed citations
17.
Coulonval, Katia, Laurence Bockstaele, Sabine Paternot, Jacques E. Dumont, & Pierre P. Roger. (2003). The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFβ, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Experimental Cell Research. 291(1). 135–149. 28 indexed citations
18.
Coulonval, Katia, Laurence Bockstaele, Sabine Paternot, & Pierre P. Roger. (2003). Phosphorylations of Cyclin-dependent Kinase 2 Revisited Using Two-dimensional Gel Electrophoresis. Journal of Biological Chemistry. 278(52). 52052–52060. 49 indexed citations
19.
Paternot, Sabine, Katia Coulonval, Jacques E. Dumont, & Pierre P. Roger. (2003). Cyclic AMP-dependent Phosphorylation of Cyclin D3-bound CDK4 Determines the Passage through the Cell Cycle Restriction Point in Thyroid Epithelial Cells. Journal of Biological Chemistry. 278(29). 26533–26540. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026